The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 26, 2016

Filed:

Jun. 29, 2012
Applicants:

David R. Liu, Lexington, MA (US);

Juan Pablo Maianti, Cambridge, MA (US);

Alan Saghatelian, Somerville, MA (US);

Ralph E. Kleiner, New York, NY (US);

Inventors:

David R. Liu, Lexington, MA (US);

Juan Pablo Maianti, Cambridge, MA (US);

Alan Saghatelian, Somerville, MA (US);

Ralph E. Kleiner, New York, NY (US);

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 14/00 (2006.01); C07K 1/00 (2006.01); C07K 7/54 (2006.01); A61K 31/395 (2006.01); C07K 5/02 (2006.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
C07K 7/54 (2013.01); A61K 31/395 (2013.01); C07K 5/0215 (2013.01); A61K 38/00 (2013.01);
Abstract

Macrocyclic compounds that specifically inhibit insulin degrading enzyme (IDE) are provided. Pharmaceutically acceptable salts, solvates, hydrates, stereoisomers, polymorphs, tautomers, isotopically enriched forms, and prodrugs of the macrocyclic IDE inhibitors are also described. Pharmaceutical compositions are also provided. In vivo and in vitro methods of using the IDE inhibitor, and pharmaceutical compositions comprising the IDE inhibitor, for example, for the inhibition of IDE in a subject exhibiting aberrant IDE activity, impaired insulin signaling, or insulin resistance, for example, a subject having diabetes, are also provided.


Find Patent Forward Citations

Loading…